Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Tax Provisions (2017 - 2021)

Historic Tax Provisions for Celldex Therapeutics (CLDX) over the last 4 years, with Q3 2021 value amounting to -$227000.0.

  • Celldex Therapeutics' Tax Provisions changed N/A to -$227000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was -$1.2 million, marking a year-over-year increase of 8.57%. This contributed to the annual value of -$227000.0 for FY2021, which is 8054.84% up from last year.
  • Latest data reveals that Celldex Therapeutics reported Tax Provisions of -$227000.0 as of Q3 2021.
  • Celldex Therapeutics' 5-year Tax Provisions high stood at -$227000.0 for Q3 2021, and its period low was -$19.1 million during Q4 2017.
  • Over the past 4 years, Celldex Therapeutics' median Tax Provisions value was -$852000.0 (recorded in 2018), while the average stood at -$4.4 million.